BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37482497)

  • 21. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.
    Meng L; Yang Y; Hu X; Zhang R; Li X
    J Transl Med; 2023 Feb; 21(1):79. PubMed ID: 36739407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis.
    Deng HY; Chen ZJ; Qiu XM; Zhu DX; Tang XJ; Zhou Q
    Nutrition; 2021 Oct; 90():111345. PubMed ID: 34166897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand Therapy.
    Hartrampf PE; Mihatsch PW; Seitz AK; Solnes LB; Rowe SP; Pomper MG; Kübler H; Bley TA; Buck AK; Werner RA
    J Nucl Med; 2023 Aug; 64(8):1272-1278. PubMed ID: 37290794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
    Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of sarcopenia on clinical outcomes in men with metastatic castrate-resistant prostate cancer.
    Papadopoulos E; Wong AKO; Law SHC; Zhang LZJ; Breunis H; Emmenegger U; Alibhai SMH
    PLoS One; 2023; 18(6):e0286381. PubMed ID: 37262068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term impact of sarcopenia in older patients undergoing gastrectomy for gastric cancer: a systematic review and meta-analysis.
    Terayama M; Ohashi M; Ri M; Makuuchi R; Hayami M; Ida S; Kumagai K; Sano T; Nunobe S
    Transl Gastroenterol Hepatol; 2023; 8():35. PubMed ID: 38021358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer.
    Kuroki LM; Mangano M; Allsworth JE; Menias CO; Massad LS; Powell MA; Mutch DG; Thaker PH
    Ann Surg Oncol; 2015 Mar; 22(3):972-9. PubMed ID: 25190123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy.
    Kelkar S; Oyekunle T; Eisenberg A; Howard L; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Klaassen Z; Terris MK; Freedland SJ; Csizmadi I
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34169227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
    Raval AD; Thakker D; Negi H; Vyas A; Kaur H; Salkini MW
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):151-62. PubMed ID: 26782711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical margin status and its impact on prostate cancer prognosis after radical prostatectomy: a meta-analysis.
    Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y; Yang W
    World J Urol; 2018 Nov; 36(11):1803-1815. PubMed ID: 29766319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
    Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
    Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients.
    Rivera-Izquierdo M; Pérez de Rojas J; Martínez-Ruiz V; Arrabal-Polo MÁ; Pérez-Gómez B; Jiménez-Moleón JJ
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):411-421. PubMed ID: 34987170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.
    Shachar SS; Williams GR; Muss HB; Nishijima TF
    Eur J Cancer; 2016 Apr; 57():58-67. PubMed ID: 26882087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors.
    Kim YY; Lee J; Jeong WK; Kim ST; Kim JH; Hong JY; Kang WK; Kim KM; Sohn I; Choi D
    Gastric Cancer; 2021 Mar; 24(2):457-466. PubMed ID: 32970267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of sarcopenic obesity on treatment outcomes in gastrointestinal cancer: A systematic review.
    Dikova TS; Zatsepina AY; Fedorinov DS; Lyadov VK
    Clin Nutr ESPEN; 2022 Feb; 47():135-146. PubMed ID: 35063193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Association Between Sarcopenia and Oncologic Outcomes After Radical Prostatectomy.
    Mason RJ; Boorjian SA; Bhindi B; Rangel L; Frank I; Karnes RJ; Tollefson MK
    Clin Genitourin Cancer; 2018 Jun; 16(3):e629-e636. PubMed ID: 29289518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between preoperative sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: a updated systematic review and meta-analysis.
    Liu C; An L; Zhang S; Deng S; Wang N; Tang H
    World J Surg Oncol; 2024 Jan; 22(1):38. PubMed ID: 38287345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sarcopenia Predicts Prognosis of Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Zhang H; Zhang L; Wang Y; Zou J; Zhang T
    Nutr Cancer; 2023; 75(3):776-784. PubMed ID: 36537813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is There a Benefit of Addition Docetaxel, Abiraterone, Celecoxib, or Zoledronic Acid in Initial Treatments for Patients Older Than 70 Years With Hormone-sensitive Advanced Prostate Cancer? A Meta-analysis.
    Landre T; Guetz GD; Chouahnia K; Fossey-Diaz V; Taleb C; Culine S
    Clin Genitourin Cancer; 2019 Aug; 17(4):e806-e813. PubMed ID: 31227430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.